Following positive research findings , retatrutide, a new peptide therapy for treating non-insulin dependent diabetes , has secured conditional approval from Great Britain's Drug and Regulatory Agency ( https://laylapvyi599112.targetblogs.com/41562251/retatrutide-treatment-peptide-united-kingdom-approval-and-launch